REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaucotech Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Scientific Research and Development Services
Full name: Glaucotech Sp. z o.o. Profile Updated: February 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Glaucotech Sp. z o.o. is an enterprise based in Poland. Its main office is in Katowice. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on December 31, 2021. Its’ total assets recorded a negative growth of 0.61%.

Headquarters
Ul. Gen. Wladyslawa Sikorskiego 45/177
Katowice; Slaskie; Postal Code: 40-282

Contact Details: Purchase the Glaucotech Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Glaucotech Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Glaucotech Sp. z o.o. report to view the information.
Incorporation Date:
December 31, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
54%
Purchase this report to view the information.
32%
Purchase this report to view the information.
14%
Company Performance
Created with Highstock 1.3.7Chart context menu2023Y2024Y
Net sales revenue
Net Profit (Loss) for the Period
Financial values in the chart are available after Glaucotech Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
98.13%
Net Profit (Loss) for the Period
97.75%
Total assets
-0.61%
Total equity
-0.75%
Return on Equity (ROE)
32.69%
Debt to Equity Ratio
0.15%
Quick Ratio
-0.59%
Cash Ratio
-0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?